リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「A case of a recurrent low-grade endometrial stromal sarcoma extending to the inferior vena cava (IVC) after the primary fertility-sparing surgery」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

A case of a recurrent low-grade endometrial stromal sarcoma extending to the inferior vena cava (IVC) after the primary fertility-sparing surgery

Yano, Yoko Yamasaki, Yui Yamanaka, Keitaro Nishimoto, Masashi Nagamata, Satoshi Terai, Yoshito 神戸大学

2023.10

概要

Introduction and importance: A case of Low-grade endometrial stromal sarcoma (LG-ESS) invading the great vessels is rare. Case presentation: A 34-year-old female who had no past history presented to a previous hospital with abdominal distension. Magnetic resonance imaging revealed a 15 cm pelvic mass beside the uterus, and only the pelvic mass was removed at the surgery. The tumor was judged to be a LG-ESS. The patient chose to be observed to preserve her fertility, and no adjuvant treatment was undertaken. Two years later, she was referred to our hospital due to recurrence of the pelvic mass. Enhanced computed tomography revealed a large tumor in the vena cava which extended from the left internal iliac vein and which originated from the pelvic tumor. An operation was performed by a multidisciplinary team. Complete resection of the tumor was achieved with a radical hysterectomy, bilateral salpingo-oophorectomy, removal of recurrent pelvic masses and the intravascular tumor. We diagnosed a recurrence of LG-ESS. She received a postoperative adjuvant therapy of LG-ESS. Clinical discussion: Patients with fertility-sparing treatment had higher recurrence rates. In cases of tumor intravenous extension, we should make every effort to extract the tumor to avoid sudden death. Conclusion: This case highlights the importance of a multidisciplinary approach in treating this rare tumor with intravascular extension. In particular, patients with LG-ESS who receive fertility-sparing surgery should undertake postoperative chemotherapy or radiotherapy in order to reduce the risk of recurrence, as was in this case.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

[1] D. Pink, T. Lindner, A. Mrozek, A. Kretzschmar, P.C. Thuss-Patience, B. D¨

orken, et

al., Harm or benefit of hormonal treatment in metastatic low-grade endometrial

stromal sarcoma. Single center experience with 10 cases and review of the

literature, Gynecol. Oncol. 101 (2006) 464–469.

[2] W. Kudaka, H. Inafuku, Y. Iraha, T. Nakamoto, Y. Taira, R. Taira, et al., Low-grade

endometrial stromal sarcoma with intravenous and intracardiac extension, a

multidisciplinary approach, Case Rep. Obstet. Gynecol. 2016 (2016) 1–6.

[3] J.L. Wei, X. Ji, P. Zhang, W.J. Chen, Y.N. Zhao, M. Liu, Complete intravenous

leiomyomatosis: a case report and literature review, Ann. Palliat. Med. 10 (2021)

12039–12045.

[4] Y. Zheng, Q. Yin, X. Yang, R. Dong, Fertility-sparing management of low-grade

endometrial stromal sarcoma: analysis of an institutional series, a population-based

analysis and review of the literature, Ann. Transl. Med. 8 (2020) 1358.

[5] K. Lo, M. Yu, T. Cheung, Low-grade endometrial stromal sarcoma with florid

intravenous component, Gynecol. Obstet. Investig. 66 (2008) 8–11.

[6] T.L. Beck, P.K. Singhal, H.M. Ehrenberg, P.G. Rose, S.B. Lele, T.C. Krivak, et al.,

Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment,

Gynecol. Oncol. 125 (2012) 141–144.

[7] F. Lipsich, P.I. Causa Andrieu, A. Wernicke, M.G. Patrono, M.N. Napoli, C.R.

B. Chacon, et al., Extra-uterine endometrial stromal sarcoma arising from deep

infiltrating endometriosis, Clin. Imaging 67 (2020) 250–254.

[8] R.P. Masand, E.D. Euscher, M.T. Deavers, A. Malpica, Endometrioid stromal

sarcoma a clinicopathologic study of 63 cases, Am. J. Surg. Pathol. 37 (2013)

1635–1647.

[9] Y. Nogami, W. Yamagami, J. Maki, K. Banno, N. Susumu, K. Tomita, et al.,

Intravenous low-grade endometrial stromal sarcoma with intracardiac extension: a

case of inaccurate tumor location on contrast-enhanced computed tomography,

Mol. Clin. Oncol. 4 (2016) 179–182.

[10] M.H. Kim, C.K. Jung, J.K. Hwang, I.S. Moon, J.I. Kim, Low-grade endometrial

stromal sarcoma with inferior vena cava extension: first report in Korea, Vasc.

Specialist Int. 30 (2014) 98–101.

[11] N. Shaili Aggarwal, N. McMillian, M. Peter Frederick, D. Gaffney, R. Giuntoli,

E. Han, et al., National Comprehensive Cancer Network Guidelines- Uterine

Neoplasms vol. 1, 2023, p. 29.

[12] Y. Zang, M. Dong, K. Zhang, C. Gao, F. Guo, Y. Wang, et al., Hormonal therapy in

uterine sarcomas, Cancer Med. 8 (2019) 1339.

[13] C.A. Leath, W.K. Huh, J. Hyde, D.E. Cohn, K.E. Resnick, N.P. Taylor, et al., A multiinstitutional review of outcomes of endometrial stromal sarcoma, Gynecol. Oncol.

105 (2007) 630–634.

[14] Ying Jin, Yan Li, Cheng-Yan Deng, Qin-Jie Tian, Hao Chen, Ling-Ya Pan, Fertilitysparing treatment of low-grade endometrial stromal sarcoma, Int. J. Clin. Exp.

Med. 8 (2015) 5818–5821.

[15] G. Laurelli, F. Falcone, C. Scaffa, E.M. Messalli, M. del Giudice, S. Losito, et al.,

Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis

of an institutional series and review of the literature, Eur. J. Obstet. Gynecol.

Reprod. Biol. 195 (2015) 61–66.

Consent

Written informed consent was obtained from the patient for publi­

cation and any accompanying images. A copy of the written consent is

available for review by the Editor-in-Chief of this journal on request.

Methods

The work has been reported in line with the SCARE criteria.

Agha RA, Franchi T, Sohrab C, Mathew G, Kirwan A, Thomas A, et al.

The SCARE 2020 guideline: updating consensus Surgical Case Report

(SCARE) guidelines. International Journal of Surgery. 2020; 84

(1):226–30.

Ethical approval

The Ethics Committee of our institution confirms that ethics approval

for case report or case series are waived.

Funding sources

This study did not receive any specific grants from funding agencies

in the public, commercial, or not-for-profit sectors.

Guarantor

Prof. Yoshito Terai.

CRediT authorship contribution statement

Yoko Yano: Writing – original draft, Investigation, Visualization.

Yui Yamasaki: Resources, Writing – review & editing, Supervision.

Keitaro Yamanaka: Resources. Masashi Nishimoto: Resources.

Satoshi Nagamata: Resources. Yoshito Terai: Resources, Visualiza­

tion, Supervision, Project administration.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る